Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXTR | P30559 | 1/20 | 0.46 |
| ▸ | CALCRL | Q16602 | 13/20 | 0.43 |
| ▸ | RAMP1 | O60894 | 2/20 | 0.43 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13907943 | 0.84 | CALCRL (0.47) | CALCRLRAMP1CYP3A4HSD11B1ALDH1A1 | |
| SCHEMBL13907858 | 0.83 | CALCRL (0.52) | CALCRLRAMP1CYP3A4 | |
| SCHEMBL13907849 | 0.82 | SMYD3 (0.48) | CALCRLRAMP1CYP3A4 | |
| SCHEMBL13907847 | 0.82 | CALCRL (0.47) | CALCRLRAMP1CYP3A4 | |
| SCHEMBL13907848 | 0.82 | CALCRL (0.45) | CALCRLRAMP1CYP3A4 | |
| SCHEMBL13907843 | 0.82 | CALCRL (0.43) | CALCRLRAMP1CYP3A4 | |
| SCHEMBL13907685 | 0.82 | CALCRL (0.41) | CALCRLRAMP1CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL13907973 | 0.81 | CALCRL (0.43) | CALCRLRAMP1CYP3A4 | |
| SCHEMBL13907684 | 0.81 | CALCRL (0.46) | CALCRLRAMP1CYP3A4HTTSMN1; SMN2 | |
| SCHEMBL13907687 | 0.81 | POLB (0.47) | CALCRLRAMP1CYP3A4ALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009034029-A2 | 1-SUBSTITUTED 4-HETEROCYCLYLPIPERIDINES FOR USE AS CGRP ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-03-19 | — | — | WO | disclosed |